Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Annals of the Rheumatic Diseases|November 29, 2013
The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?M A Karsdal, A C Bay-Jensen, R J Lories, et al.
Osteoarthritis and Cartilage|November 13, 2013
Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnoverA S Siebuhr, K K Petersen, L Arendt-Nielsen, et al.
Clinical & Experimental Metastasis|April 7, 2004
Measurement of tumor load and distribution in a model of cancer-induced osteolysis: a necessary precaution when testing novel anti-resorptive therapiesR Nic Amhlaoibh, P Hoegh-Andersen, N Brünner, et al.
Osteoarthritis and Cartilage|August 6, 2016
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the futureM A Karsdal, M Michaelis, C Ladel, et al.
Scientific Reports|April 9, 2020
Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivoD Reker, A S Siebuhr, C S Thudium, et al.
Osteoarthritis and Cartilage|November 30, 2011
Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscusB C Sondergaard, P Catala-Lehnen, A K Huebner, et al.
Osteoarthritis and Cartilage|September 11, 2014
Association between biochemical cartilage markers and clinical symptoms in patients with hip osteoarthritis: cohort study with 2-year follow-upD M J Dorleijn, P A J Luijsterburg, A C Bay-Jensen, et al.
Scandinavian Journal of Rheumatology|October 21, 2015
Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?A S Siebuhr, A C Bay-Jensen, J M Jordan, et al.
United European Gastroenterology Journal|December 22, 2020
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's diseaseT Manon-Jensen, S Sun, M Lindholm, et al.
Pageof 14